Difference between revisions of "CTSC:education library"
From NAMIC Wiki
| Line 5: | Line 5: | ||
* Dynamic contrast enhanced MRI in prostate cancer, R. Alonzi, Eur. J. Radiol. 2007, 63 (3), 328-334 | * Dynamic contrast enhanced MRI in prostate cancer, R. Alonzi, Eur. J. Radiol. 2007, 63 (3), 328-334 | ||
'''doi''':10.1016/j.ejrad.2007.06.028 | '''doi''':10.1016/j.ejrad.2007.06.028 | ||
| − | |||
==Biomarkers== | ==Biomarkers== | ||
Revision as of 19:49, 28 October 2010
Home < CTSC:education libraryBack to Collaboration:Harvard_CTSC
DCE-MRI
- Dynamic contrast enhanced MRI in prostate cancer, R. Alonzi, Eur. J. Radiol. 2007, 63 (3), 328-334
doi:10.1016/j.ejrad.2007.06.028
Biomarkers
- Surrogate Endpoints And FDA’s Accelerated Approval Process, Thomas R. Fleming, Heath Affairs, 2005, 24 (1) 67-78
doi: 10.1377/hlthaff.24.1.67
Tumor response
- New Guidelines to Evaluate the Response to Treatment in Solid Tumors, P. Therasse, Journal of the National Cancer Institute, 2000, 92 (3), 205-216
- Measurement of Clinical and Subclinical Tumour Response Using [18F]-Fuorodeoxyglucose and Positron Emission Tomography: Review and 1999 EORTC Recommendations, H. Young, European Journal of Cancer, 1999, 35 (13), 1773-1782
